Growing global allergy prevalence, particularly allergic rhinitis and chronic urticaria, is significantly driving the demand for second-generation antihistamines.
Industry Overview
Desloratadine Desloratadine is an antihistamine that is used to obtain relief from allergic symptoms like sneezing, rhinorrhea, and rashes resulting from chronic reactions. The expansion in the global market for desloratadine is fueled by drivers such as the rise in prevalence of allergic rhinitis & nasal congestion and extensive use of desloratadine against multiple allergic reactions such as runny nose, watery eyes or itchy, and sneezing. Moreover, desloratadine is utilized to dismiss the symptoms of chronic hives. Though, side effects generated by anti-histamines, like fatigue, dry mouth, headache, vomiting, and gastrointestinal troubles, inhibit the growth of the market. The growing demand for the application of desloratadine in acne treatment is anticipated to provide many opportunities for the development of the market over the forecast period.
Click to get a Sample PDF (Including Full TOC, Graphs & Charts, Table & Figures) @
https://api.omrglobal.com/request-sample/Desloratadine-Market/
Market Drivers
Recent studies leading to the curing of some cancers has helped in the market growth
Bladder cancer has been increasing in numbers around the globe, for instance, the American Cancer Society estimates that approximately 84,870 new bladder cancer cases have been diagnosed in the US for 2025. In addition, approximately 17,420 deaths due to the bladder cancer are reported. Desloratadine inhibited the cell viability of EJ and SW780 cells in a time- and dose-dependent fashion. Desloratadine treatment was also revealed to inhibit colony-formation capacity and induce cell cycle arrest at the G1 phase in EJ cells. Desloratadine encouraged cell apoptosis by regulating the expression levels of Bcl-2, Bax, cleaved caspase 3, and cleaved caspase 9 in EJ and SW780 cells. Moreover, desloratadine inhibits invasion, cell migration, and epithelial to mesenchymal transition in bladder cancer cells.
For Full Report Description + Research Methodology + Table of Content + Infographics @
https://api.omrglobal.com/report-gallery/desloratadine-market/
Desloratadine Market Segmentation Analysis
Global Desloratadine Market by Source
- Pharmaceutical Manufacturers (Branded & Generic)
- Contract Manufacturing Organizations (CMOs)
- Research-Grade Suppliers
Global Desloratadine Market by End-Use Industries
- Pharmaceutical Industry
- Hospitals & Clinics
- Research Institutions
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- ASEAN Economies (Singapore, Thailand, Vietnam, Indonesia, and Other)
- Australia and New Zealand
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East and Africa
Anurag Tiwari
Director Sales Division
+91 780-304-0404
info@omrglobal.com
Visit us on social media:
Facebook | X | LinkedIn
